Cargando…

Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study

OBJECTIVES: The treatment workload associated with end-stage kidney disease (ESKD) is high. The treatment burdens experienced by patients with ESKD are not well understood. In this study, we aimed to elucidate the most important areas of treatment burden for discussion in a clinical encounter from t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Sarah T, Sav, Adem, Thomas, Rae, Cardona, Magnolia, Michaleff, Zoe, Titus, Thomas T, Dobler, Claudia C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723855/
https://www.ncbi.nlm.nih.gov/pubmed/36576180
http://dx.doi.org/10.1136/bmjopen-2022-064447
_version_ 1784844276486635520
author Thomas, Sarah T
Sav, Adem
Thomas, Rae
Cardona, Magnolia
Michaleff, Zoe
Titus, Thomas T
Dobler, Claudia C
author_facet Thomas, Sarah T
Sav, Adem
Thomas, Rae
Cardona, Magnolia
Michaleff, Zoe
Titus, Thomas T
Dobler, Claudia C
author_sort Thomas, Sarah T
collection PubMed
description OBJECTIVES: The treatment workload associated with end-stage kidney disease (ESKD) is high. The treatment burdens experienced by patients with ESKD are not well understood. In this study, we aimed to elucidate the most important areas of treatment burden for discussion in a clinical encounter from the perspectives of patients with ESKD and nephrologists. We sought to explore possible solutions to these high priority treatment burden challenges. DESIGN: Nominal group technique (NGT) sessions. SETTING AND PARTICIPANTS: Three in-person NGT sessions were conducted with 19 patients with dialysis-dependent ESKD from one tertiary treatment centre (mean age 64 years; range 47–82). All patients were either retired or on a disability pension; 74% perceived moderate or severe treatment burden; and 90% spent more than 11 hours on treatment-related activities per week (range 11–30). One online NGT session was conducted with six nephrologists from two Australian states. MAIN OUTCOME MEASURES: The primary outcome was a ranked list of treatment burden priorities. The secondary outcome was potential solutions to these treatment burden challenges. RESULTS: Every patient group ranked health system issues as the most important treatment burden priority. This encompassed lack of continuity and coordination of care, dissatisfaction with frequent healthcare encounters and challenges around healthcare access. Psychosocial burdens on patients and families were perceived to be the most important area of treatment burden by physicians, and were ranked the second highest priority by patients. CONCLUSIONS: Discussing treatment burden in a clinical encounter may lead to a better understanding of patients’ capacity to cope with their treatment workload. This could facilitate tailored care, improve health outcomes, treatment sustainability and patients’ overall quality of life.
format Online
Article
Text
id pubmed-9723855
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-97238552022-12-07 Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study Thomas, Sarah T Sav, Adem Thomas, Rae Cardona, Magnolia Michaleff, Zoe Titus, Thomas T Dobler, Claudia C BMJ Open Renal Medicine OBJECTIVES: The treatment workload associated with end-stage kidney disease (ESKD) is high. The treatment burdens experienced by patients with ESKD are not well understood. In this study, we aimed to elucidate the most important areas of treatment burden for discussion in a clinical encounter from the perspectives of patients with ESKD and nephrologists. We sought to explore possible solutions to these high priority treatment burden challenges. DESIGN: Nominal group technique (NGT) sessions. SETTING AND PARTICIPANTS: Three in-person NGT sessions were conducted with 19 patients with dialysis-dependent ESKD from one tertiary treatment centre (mean age 64 years; range 47–82). All patients were either retired or on a disability pension; 74% perceived moderate or severe treatment burden; and 90% spent more than 11 hours on treatment-related activities per week (range 11–30). One online NGT session was conducted with six nephrologists from two Australian states. MAIN OUTCOME MEASURES: The primary outcome was a ranked list of treatment burden priorities. The secondary outcome was potential solutions to these treatment burden challenges. RESULTS: Every patient group ranked health system issues as the most important treatment burden priority. This encompassed lack of continuity and coordination of care, dissatisfaction with frequent healthcare encounters and challenges around healthcare access. Psychosocial burdens on patients and families were perceived to be the most important area of treatment burden by physicians, and were ranked the second highest priority by patients. CONCLUSIONS: Discussing treatment burden in a clinical encounter may lead to a better understanding of patients’ capacity to cope with their treatment workload. This could facilitate tailored care, improve health outcomes, treatment sustainability and patients’ overall quality of life. BMJ Publishing Group 2022-12-05 /pmc/articles/PMC9723855/ /pubmed/36576180 http://dx.doi.org/10.1136/bmjopen-2022-064447 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Renal Medicine
Thomas, Sarah T
Sav, Adem
Thomas, Rae
Cardona, Magnolia
Michaleff, Zoe
Titus, Thomas T
Dobler, Claudia C
Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title_full Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title_fullStr Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title_full_unstemmed Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title_short Patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
title_sort patient and physician perspectives on treatment burden in end-stage kidney disease: a nominal group technique study
topic Renal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723855/
https://www.ncbi.nlm.nih.gov/pubmed/36576180
http://dx.doi.org/10.1136/bmjopen-2022-064447
work_keys_str_mv AT thomassaraht patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT savadem patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT thomasrae patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT cardonamagnolia patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT michaleffzoe patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT titusthomast patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy
AT doblerclaudiac patientandphysicianperspectivesontreatmentburdeninendstagekidneydiseaseanominalgrouptechniquestudy